Skip to main content

and
  1. Article

    Open Access

    High throughput platform technology for rapid target identification in personalized phage therapy

    As bacteriophages continue to gain regulatory approval for personalized human therapy against antibiotic-resistant infections, there is a need for transformative technologies for rapid target identification th...

    Fereshteh Bayat, Arwa Hilal, Mathura Thirugnanasampanthar in Nature Communications (2024)

  2. Article

    Open Access

    Virulent coliphages in 1-year-old children fecal samples are fewer, but more infectious than temperate coliphages

    Bacteriophages constitute an important part of the human gut microbiota, but their impact on this community is largely unknown. Here, we cultivate temperate phages produced by 900 E. coli strains isolated from 64...

    Aurélie Mathieu, Moïra Dion, Ling Deng, Denise Tremblay in Nature Communications (2020)

  3. Article

    Open Access

    7-Deazaguanine modifications protect phage DNA from host restriction systems

    Genome modifications are central components of the continuous arms race between viruses and their hosts. The archaeosine base (G+), which was thought to be found only in archaeal tRNAs, was recently detected in g...

    Geoffrey Hutinet, Witold Kot, Liang Cui, Roman Hillebrand in Nature Communications (2019)

  4. No Access

    Article

    A proposed new bacteriophage subfamily: “Jerseyvirinae

    Based on morphology and comparative nucleotide and protein sequence analysis, a new subfamily of the family Siphoviridae is proposed, named “Jerseyvirinae” and consisting of three genera, “Jerseylikevirus”, “Sp3u...

    Hany Anany, Andrea I. Moreno Switt, Niall De Lappe in Archives of Virology (2015)